Publications by authors named "Keyong Xiong"

Claim this Profile
R
RNA interference targeting the R2 subunit of ribonucleotide reductase inhibits growth of tumor cells in vitro and in vivo.
Tina M Avolio, Yoon Lee, Ningping Feng, Keyong Xiong, Hongnan Jin

Anticancer Drugs· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GTI-2501, an antisense agent targeting R1, the large subunit of human ribonucleotide reductase, shows potent anti-tumor activity against a variety of tumors.
Yoon Lee, Aikaterini Vassilakos, Ningping Feng, Hongnan Jin, Ming Wang, Keyong Xiong

Int J Oncol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-proliferative and anti-tumor effects of antisense oligonucleotide GTI-2601 targeted against human thioredoxin.
Yoon Lee, Aikaterini Vassilakos, Ningping Feng, Tina Avolio, Hongnan Jin, Keyong Xiong

Anticancer Drugs· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenovirus-mediated ribonucleotide reductase R1 gene therapy of human colon adenocarcinoma.
Ming-Yu Cao, Yoon Lee, Ning-Ping Feng, Keyong Xiong, Hongnan Jin

Clin Cancer Res· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GTI-2040, an antisense agent targeting the small subunit component (R2) of human ribonucleotide reductase, shows potent antitumor activity against a variety of tumors.
Yoon Lee, Aikaterini Vassilakos, Ningping Feng, Viengthong Lam, Hongsheng Xie, Keyong Xiong

Cancer Res· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis